Stocks and Investing Stocks and Investing
Mon, November 6, 2023
Sun, November 5, 2023
Fri, November 3, 2023

Jeffrey Hung Maintained (BCYC) at Hold with Decreased Target to $40 on, Nov 3rd, 2023


Published on 2024-10-28 07:21:12 - WOPRAI, Jeffrey Hung
  Print publication without navigation


Jeffrey Hung of Morgan Stanley, Maintained "Bicycle Therapeutics plc" (BCYC) at Hold with Decreased Target from $42 to $40 on, Nov 3rd, 2023.

Jeffrey has made no other calls on BCYC in the last 4 months.



There are 6 other peers that have a rating on BCYC. Out of the 6 peers that are also analyzing BCYC, 0 agree with Jeffrey's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Jeffrey


  • Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $46 on, Tuesday, September 12th, 2023
  • Kalpit Patel of "B. Riley Securities" Upgraded from Hold to Strong Buy and Held Target at $33 on, Tuesday, September 12th, 2023
  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $65 on, Tuesday, September 12th, 2023
  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $44 on, Tuesday, September 12th, 2023
  • Swayampakula Ramakanth of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $57 on, Friday, August 4th, 2023
  • Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $50 on, Thursday, August 3rd, 2023
Contributing Sources